| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2078428 | Cell Stem Cell | 2016 | 5 Pages |
Abstract
While advanced therapy medicinal products offer great clinical promise, most EU-approved products have not achieved satisfactory commercial performance. Here we highlight a number of issues that prevent current products from obtaining commercial success and pitfalls that developers must overcome in future product development.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Biotechnology
Authors
Mohamed Abou-El-Enein, Ahmed Elsanhoury, Petra Reinke,